In serous ovarian carcinoma, strong expression of BMP-4 before chemotherapy was an independent prognostic factor of longer progression-free time and overall survival, but it was not associated with neovascularization [31]. This evidence concerns the gene BMP4 and ovarian serous carcinoma.